A GDF-15 concentration above 1214 pg/mL diagnosed PMM vs. CFS with 86% sensitivity and 91% specificity (correctly classified 89% of the patients). This evidence concerns the gene GDF15 and myalgic encephalomeyelitis/chronic fatigue syndrome.